INHIBITION OF GLUTAMINYL CYCLASE ENHANCES INACTIVATION OF CCL2: A POTENTIAL THERAPY FOR CARDIOVASCULAR DISEASE

被引：0
|
作者：
Cynis, H. [1 ]
Hoffmann, T. [2 ]
Schilling, S. [1 ]
Demuth, H-U
机构：
[1] Probiodrug AG, Enzymol, Halle, Germany
[2] Probiodrug AG, In Vitro Pharmacol, Halle, Germany
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2009年 / 10卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma
    Ding, Liang
    Li, Bing
    Zhao, Ying
    Fu, Yi-Fu
    Hu, Er-Ling
    Hu, Qin-Gang
    Ni, Yan-Hong
    Hou, Ya-Yi
    TUMOR BIOLOGY, 2014, 35 (10) : 10539 - 10546
  • [42] Potential of renin inhibition in cardiovascular disease
    Stanton, A
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2003, 4 (01) : 6 - 10
  • [43] CCL2 Responses to Mycobacterium tuberculosis Are Associated with Disease Severity in Tuberculosis
    Hasan, Zahra
    Cliff, Jacqueline M.
    Dockrell, Hazel M.
    Jamil, Bushra
    Irfan, Muhammad
    Ashraf, Mussarat
    Hussain, Rabia
    PLOS ONE, 2009, 4 (12):
  • [44] PHOTOELECTRON-SPECTRUM, IONIZATION-POTENTIAL, AND HEAT OF FORMATION OF CCL2
    KOHN, DW
    ROBLES, ESJ
    LOGAN, CF
    CHEN, P
    JOURNAL OF PHYSICAL CHEMISTRY, 1993, 97 (19): : 4936 - 4940
  • [45] REDUCED GLIOSIS AFTER CHRONIC INHIBITION OF GLUTAMINYL CYCLASE IN ALZHEIMER'S DISEASE TG2576 MICE
    Rossner, S.
    Zeitschel, U.
    Schilling, S.
    Hoffmann, T.
    Demuth, H. U.
    GLIA, 2009, 57 (13) : S94 - S94
  • [46] Autophagy genes CCL2 and MYC are considered as potential biomarkers for pulmonary embolism
    Zhang, Xuehui
    Yang, Naibin
    Shao, Lijiang
    Chen, Xuxia
    Chen, Xueqin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (08): : 5896 - +
  • [47] CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
    Arakaki, Ryuichiro
    Yamasaki, Toshinari
    Kanno, Toru
    Shibasaki, Noboru
    Sakamoto, Hiromasa
    Utsunomiya, Noriaki
    Sumiyoshi, Takayuki
    Shibuya, Shinsuke
    Tsuruyama, Tatsuaki
    Nakamura, Eijiro
    Ogawa, Osamu
    Kamba, Tomomi
    CANCER MEDICINE, 2016, 5 (10): : 2920 - 2933
  • [48] CCL2 chemokine inhibition primes the tumor vasculature for improved nanomedicine delivery and efficacy
    Moeckel, Diana
    Bartneck, Matthias
    Niemietz, Patricia
    Wagner, Maike
    Ehling, Josef
    Rama, Elena
    Weiler, Marek
    Gremse, Felix
    Eulberg, Dirk
    Pola, Robert
    Pechar, Michal
    Etrych, Tomas
    Storm, Gert
    Kiessling, Fabian
    Tacke, Frank
    Lammers, Twan
    JOURNAL OF CONTROLLED RELEASE, 2024, 365 : 358 - 368
  • [49] Strategies for inhibition of chemokine (CCL2) mediated monocyte migration in lethal reperfusion injury
    Saleki, M.
    Ali, S.
    Dark, J. H.
    Kirby, J.
    BRITISH JOURNAL OF SURGERY, 2012, 99 : 13 - 13
  • [50] Natural Products from Microalgae with Potential against Alzheimer's Disease: Sulfolipids Are Potent Glutaminyl Cyclase Inhibitors
    Hielscher-Michael, Stephanie
    Griehl, Carola
    Buchholz, Mirko
    Demuth, Hans-Ulrich
    Arnold, Norbert
    Wessjohann, Ludger A.
    MARINE DRUGS, 2016, 14 (11):
12345